These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10725724

  • 1. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM, Peijnenburg A, Gobin SJ, Boss JM, van den elsen PJ.
    J Immunol; 2000 Apr 01; 164(7):3666-74. PubMed ID: 10725724
    [Abstract] [Full Text] [Related]

  • 2. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
    Peijnenburg A, Van Eggermond MJ, Gobin SJ, Van den Berg R, Godthelp BC, Vossen JM, Van den Elsen PJ.
    J Immunol; 1999 Jul 15; 163(2):794-801. PubMed ID: 10395672
    [Abstract] [Full Text] [Related]

  • 3. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB, Ferguson AM, Majumder P, Nagarajan UM, Boss JM.
    Mol Immunol; 2006 Feb 15; 43(5):395-409. PubMed ID: 16337482
    [Abstract] [Full Text] [Related]

  • 4. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W.
    Nat Genet; 1998 Nov 15; 20(3):273-7. PubMed ID: 9806546
    [Abstract] [Full Text] [Related]

  • 5. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S, Purushothaman P, Gupta N, Challa S, Cai Q, Verma SC.
    J Virol; 2015 May 15; 89(10):5536-56. PubMed ID: 25740990
    [Abstract] [Full Text] [Related]

  • 6. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
    Gobin SJ, Peijnenburg A, van Eggermond M, van Zutphen M, van den Berg R, van den Elsen PJ.
    Immunity; 1998 Oct 15; 9(4):531-41. PubMed ID: 9806639
    [Abstract] [Full Text] [Related]

  • 7. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q, De Palma R, Krawczyk M, Leimgruber E, Villard J, Picard C, Tagliamacco A, Abbate G, Gorski J, Nocera A, Reith W.
    J Immunol; 2009 Aug 15; 183(4):2545-53. PubMed ID: 19620312
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
    Schmetterer KG, Seidel MG, Körmöczi U, Rottal A, Schwarz K, Matthes-Martin S, Steinberger P, Pickl WF.
    Int Arch Allergy Immunol; 2010 Aug 15; 152(4):390-400. PubMed ID: 20197681
    [Abstract] [Full Text] [Related]

  • 10. Mutation in the class II trans-activator leading to a mild immunodeficiency.
    Wiszniewski W, Fondaneche MC, Le Deist F, Kanariou M, Selz F, Brousse N, Steimle V, Barbieri G, Alcaide-Loridan C, Charron D, Fischer A, Lisowska-Grospierre B.
    J Immunol; 2001 Aug 01; 167(3):1787-94. PubMed ID: 11466404
    [Abstract] [Full Text] [Related]

  • 11. The bare lymphocyte syndrome and the regulation of MHC expression.
    Reith W, Mach B.
    Annu Rev Immunol; 2001 Aug 01; 19():331-73. PubMed ID: 11244040
    [Abstract] [Full Text] [Related]

  • 12. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GR, Boss JM, Ting JP.
    Immunity; 1994 Nov 01; 1(8):687-97. PubMed ID: 7600294
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
    Brickey WJ, Wright KL, Zhu XS, Ting JP.
    J Immunol; 1999 Dec 15; 163(12):6622-30. PubMed ID: 10586057
    [Abstract] [Full Text] [Related]

  • 14. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K, Reith W.
    EMBO J; 2002 Mar 15; 21(6):1379-88. PubMed ID: 11889043
    [Abstract] [Full Text] [Related]

  • 15. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J, Muhlethaler-Mottet A, Bontron S, Mach B, Reith W.
    Int Immunol; 1999 Mar 15; 11(3):461-9. PubMed ID: 10221658
    [Abstract] [Full Text] [Related]

  • 16. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
    Taxman DJ, Cressman DE, Ting JP.
    J Immunol; 2000 Aug 01; 165(3):1410-6. PubMed ID: 10903745
    [Abstract] [Full Text] [Related]

  • 17. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
    Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W.
    EMBO J; 1997 Mar 03; 16(5):1045-55. PubMed ID: 9118943
    [Abstract] [Full Text] [Related]

  • 18. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    Bradley MB, Fernandez JM, Ungers G, Diaz-Barrientos T, Steimle V, Mach B, O'Reilly R, Lee JS.
    J Immunol; 1997 Aug 01; 159(3):1086-95. PubMed ID: 9233601
    [Abstract] [Full Text] [Related]

  • 19. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.
    Peijnenburg A, Gobin SJ, van Eggermond MC, Godthelp BC, van Graafeiland N, van den Elsen PJ.
    J Immunol; 1997 Sep 15; 159(6):2720-7. PubMed ID: 9300692
    [Abstract] [Full Text] [Related]

  • 20. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W, Fondaneche MC, Louise-Plence P, Prochnicka-Chalufour A, Selz F, Picard C, Le Deist F, Eliaou JF, Fischer A, Lisowska-Grospierre B.
    Immunogenetics; 2003 Feb 15; 54(11):747-55. PubMed ID: 12618906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.